The vitro and vivo study of Poly (3-hydroxybutyrate) microspheres

IFMBE Proceedings

Volumn 19 IFMBE, Issue , 2008, Pages 615-622

  Tian, Feng ^a   Zhao, Yong Liang ^a   Liu, Chang Jun ^a   Li, Fan ^a   Xing, Nan ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

BSA; controlled release; histological examination; Poly (3 hydroxybutyrate) microspheres; vitro cytotoxicity

Indexed keywords

BIOCOMPATIBILITY; CYTOTOXICITY; LEACHING; MAMMALS; MICROSPHERES; TARGETED DRUG DELIVERY;

CONTROLLED RELEASE; CONTROLLED RELEASE DEVICES; CONTROLLED RELEASE DRUGS; ENCAPSULATION EFFICIENCY; HISTOLOGICAL EXAMINATION; POLY-3-HYDROXYBUTYRATE; SOLVENT EVAPORATION METHOD; VITRO CYTOTOXICITIES;

CONTROLLED DRUG DELIVERY;

EID: 78049361616     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-540-79039-6_153     Document Type: Conference Paper

References (27)

1. Jeffery, H., Davis,S.S., & O,Hagan,D.T. (1991) The preparation and characterization of poly(lactide-co-glycolide) microparticles.I.Oil-inwater emulsion solvent evaporation.International Journal of Pharmacy 77,169-175.
2. Jeffery, H., Davis,S.S., & O'Hagan,D.T. (1993 ) The preparation and characterization of poly(lactide-co-glycolide) microparticles.II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique.Pharmacy Research 10,362-368.
3. Metha, R.C., Thanoo,B.C., & Deluca,P.P. (1996) Peptide containing microspheres from low molecular weight and hydrophilic poly (DL-lactide-co- glycolide).Journal of Controlled Release 41, 249-257.
4. Narayani R, Rao KP. (1996) Gelatin microsphere cocktails of different sizes for the controlled release of anticancer drugs. Int J Pharm 143,255-8.
5. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. (2002) PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Controlled Rel 79, 123-35.
6. Le Ray AM, Chiffoleau S, Iooss P, Grimandi G, Gouyette A, Daculsi G, Merle C. (2003) Vancomycin encapsulation in biodegradable poly (e-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility. Biomaterials 24, 443-9.
7. Carino GP, Jacob JS, Mathiowitz E. (2000) Nanosphere based oral insulin delivery. J Controlled Rel 65, 261-9.
8. B.R. Conway, J.E. Eyles, H.O.Alpar. (1997) A comparative study on the immune responses to antigens in PLA and PHB microspheres. Journal of Controlled Release 49, 1-9.
9. Augusta E. M. Collins, P. B. Deasy, Dense J. Maccarthy and D. B. Shanley. (1989) Evaluation of a controlled-release compact containing tetracycline hydrochloride bonded to tooth for the treatment of periodeontal disease International journal of pharmaceutics 51, 103-114.
10. Saghir Akhtar, Conlin. Pouton and Lidia (1992) Notaianni. Crystallizaation behaviour and drug release from bacterial polyhydroxyalkanoates. J. polymer 33, 117-126.
11. Saghir Akhtar, Cofin W.Pouton and Lidia J. Notarianni.. (1991) The influence of crystalline morphology and copolymer compostion on drug release from solution cast and melt-processed P(HB-HV) co-polymer matrices Journal of controlled release 17, 225-233.
12. Kazuhiko Juni, Masahiro Nakano and Miho Kubota. (1986) Controlled release of aclarubicim, an anticancer antibiotic, from poly-β-hydroxybutyric acid microspheres J. Control. Release 4, 25-32.
13. Wei Jen Shih, Yi-Hung Chen, Chi Jen ShIH, Min Hsiung Hon, Moo Chin Wang. (2007) Structural and morphological studies on poly(3-hydroxybutyrate acid)(PHB)/chitosan drug releasing microspheres prepared by both single and double emulsion processes Journal of Alloys and Compounds 434-435, 826-829.
14. Chen GQ, Wu Q. Polyhydroxyalkanoates as tissue engieering materials. (2005)Biomaterials 26:6565-6578.
15. Wang YW, Wu Q, Chen GQ. Reduced mouse fibroblast cell growth by increased hydrophilicity of microbial polyhydroxyalkanoates via hyaluronan coating. (2003) Biomaterials 24:4621-4629.
16. GB/T16886.5-2003, Biological evaluation of medical devices-Part 5: Test for in vitro cytotoxicity.
17. Y.Y. Yang, T.S.Chung, X.L. Bai, W.K. Chan. (2000) Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein prepared by double emulsion method Chem. Eng. Sci. 55, 2223-2236.
18. M.K. Yeh, A.G.A. Coombes, P.G.Jenkins, S.S. Davis. (1995) A novel emulsification-solvent extraction technique for production of protein loaded biodegradable microparticles for vaccine and drug delivery, J. Control. Release 33, 437-445.
19. G.T. Kose, H. Kenar, N. Hasirci, V. Hasirci, (2003) Biomaterials 24, 1949-1958.
20. D. Sendil, I.Gursel, D. L. Wise, V. Hasirci, (1999) J. Control. Release 59, 207-217.
21. Anderson JM. In vivo biocompatibility of implantation delivery systems and biomaterials.(1994) Eur J Pharm Biopharm 40:1-8.
22. Anderson JM. Inflammation and the foreign body response. (1994)Prob Gen Surgery 11:147-160.
23. Visscher GE, Pearsonn JE, Fong JW, Argenticri GJ, Robinson RL, Maulding HV. Effect of particle size on the in vitro and in vivo degradation rates of poly (DL-lactide-co-glycolide) microcapsules. [1988] J Biomed Mater Res 22:733-746.
24. Visscher GE, Robinson RL, Maulding HV, Fong JW, pearsonn JE, Argenticri GJ. Biodegradation of and tissue reaction to poly (DL-lactide-co-glycolide) microcapsules. (1986)J Biomed Mater Res 20:667-76.
25. Ziats NP, Miller KM, Anderson JM. In vivo and in vitro interaction of cells with biomaterials.(1988) Biomaterials 9:5-13.
26. Ward PA, Recruitment of inflammatory cells into lung: roles of cytokines, adhesion molecules, and complement. (1997) J Lab Clin Med 29:400-404.
27. Lapp CA, Schuster GS. Effects of DMAEMA and 4-methoxyphenol on gingival fibroblast growth, metabolism, and response to interleukin21. (2002) J BiomedMaterRes, 60 (1): 30-35.